Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.

Morgan MA, Darcy KM, Rose PG, DeGeest K, Bookman MA, Aikins JK, Sill MW, Mannel RS, Allievi C, Egorin MJ; Gynecologic Oncology Group.

Gynecol Oncol. 2008 Sep;110(3):329-35. doi: 10.1016/j.ygyno.2008.05.008. Epub 2008 Jul 1.

PMID:
18597837
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.

Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, Degeest K, Yamada SD, Waggoner S, Coleman RL, Walker JL, Mannel RS.

Gynecol Oncol. 2011 May 1;121(2):264-8. doi: 10.1016/j.ygyno.2010.12.358. Epub 2011 Feb 1.

PMID:
21277623
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gould N, Sill MW, Mannel RS, Thaker PH, Disilvestro P, Waggoner S, Yamada SD, Armstrong DK, Wenzel L, Huang H, Fracasso PM, Walker JL.

Gynecol Oncol. 2012 Apr;125(1):54-8. doi: 10.1016/j.ygyno.2011.12.417. Epub 2011 Dec 11.

PMID:
22155262
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gould N, Sill MW, Mannel RS, Thaker PH, DiSilvestro PA, Waggoner SE, Yamada SD, Armstrong DK, Fracasso PM, Walker JL.

Gynecol Oncol. 2012 Dec;127(3):506-10. doi: 10.1016/j.ygyno.2012.08.037. Epub 2012 Aug 31.

PMID:
22943879
[PubMed - indexed for MEDLINE]
5.

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study.

Tiersten AD, Sill MW, Knight D, Muggia F, Garcia AA, Swensen R, Warshal DP, Mannel RS, Fracasso PM.

Gynecol Oncol. 2010 Sep;118(3):303-7. doi: 10.1016/j.ygyno.2010.05.020. Epub 2010 Jun 14.

PMID:
20547415
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.

Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH.

Cancer Chemother Pharmacol. 2013 Jul;72(1):101-7. doi: 10.1007/s00280-013-2173-2. Epub 2013 May 10.

PMID:
23660691
[PubMed - indexed for MEDLINE]
7.

Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.

Rose PG, Rodriguez M, Waggoner S, Greer BE, Horowitz IR, Fowler JM, McGuire WP.

J Clin Oncol. 2000 Aug;18(16):2957-62.

PMID:
10944128
[PubMed - indexed for MEDLINE]
8.

A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study.

Sabbatini P, Sill MW, O'Malley D, Adler L, Secord AA; Gynecologic Oncology Group Study.

Gynecol Oncol. 2008 Dec;111(3):455-60. doi: 10.1016/j.ygyno.2008.07.049. Epub 2008 Sep 30.

PMID:
18829087
[PubMed - indexed for MEDLINE]
9.

Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.

Rose PG, Greer BE, Horowitz IR, Markman M, Fusco N.

Gynecol Oncol. 2007 Jan;104(1):114-9. Epub 2006 Sep 7.

PMID:
16959305
[PubMed - indexed for MEDLINE]
10.

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.

Look KY, Bookman MA, Schol J, Herzog TJ, Rocereto T, Vinters J; Gynecologic Oncology Group Study.

Gynecol Oncol. 2004 Jan;92(1):93-100.

PMID:
14751144
[PubMed - indexed for MEDLINE]
11.

Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers.

Escobar PF, Markman M, Rose P, Zanotti K, Webster K, Belinson J.

Gynecol Oncol. 2004 Jan;92(1):192-6.

PMID:
14751157
[PubMed - indexed for MEDLINE]
12.

Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I study.

Prince HM, Rischin D, Quinn M, Allen D, Planner R, Neesham D, Gates P, Davison J.

Gynecol Oncol. 2001 May;81(2):216-24.

PMID:
11330952
[PubMed - indexed for MEDLINE]
13.

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: a gynecologic oncology group study.

Dizon DS, Sill MW, Gould N, Rubin SC, Yamada SD, Debernardo RL, Mannel RS, Eisenhauer EL, Duska LR, Fracasso PM.

Gynecol Oncol. 2011 Nov;123(2):182-6. doi: 10.1016/j.ygyno.2011.07.016. Epub 2011 Aug 5.

PMID:
21820161
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer.

Micha JP, Goldstein BH, Rettenmaier MA, Mattison J, Graham C, Birk CL, Brown JV.

Gynecol Oncol. 2004 Sep;94(3):719-24.

PMID:
15350364
[PubMed - indexed for MEDLINE]
15.

Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial.

Markman M, Glass T, Smith HO, Hatch KD, Weiss GR, Taylor SA, Goodwin JW, Alberts DS.

Gynecol Oncol. 2003 Mar;88(3):282-8.

PMID:
12648576
[PubMed - indexed for MEDLINE]
16.

Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.

Nagao S, Iwasa N, Kurosaki A, Nishikawa T, Ohishi R, Hasegawa K, Goto T, Fujiwara K.

Int J Gynecol Cancer. 2012 Jan;22(1):70-5. doi: 10.1097/IGC.0b013e318234f927.

PMID:
22146766
[PubMed - indexed for MEDLINE]
17.

A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.

Gibbs DD, Pyle L, Allen M, Vaughan M, Webb A, Johnston SR, Gore ME.

Br J Cancer. 2002 May 6;86(9):1379-84.

PMID:
11986767
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer.

Leiser AL, Maluf FC, Chi DS, Sabbatini P, Hensley ML, Schwartz L, Venkatraman E, Spriggs D, Aghajanian C.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):379-86.

PMID:
17362316
[PubMed - indexed for MEDLINE]
19.

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.

Konner J, Schilder RJ, DeRosa FA, Gerst SR, Tew WP, Sabbatini PJ, Hensley ML, Spriggs DR, Aghajanian CA.

Gynecol Oncol. 2008 Aug;110(2):140-5. doi: 10.1016/j.ygyno.2008.04.018. Epub 2008 Jun 13.

PMID:
18554700
[PubMed - indexed for MEDLINE]
20.

Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum.

Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J.

J Clin Oncol. 2001 Apr 1;19(7):1901-5.

PMID:
11283121
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk